2027 ICD-10-CM Diagnosis Code G25.71Drug induced akathisia

ICD-10-CM Codes›G00–G99›G20-G26›G25

ICD-10-CM G25.71
CMSSource: CMS FY 2027 ICD-10-CM dataset · Effective Oct 1, 2026 – Sep 30, 2027

G25.71 is a billable ICD-10-CM diagnosis code for drug induced akathisia. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to MS-DRG 56 through 57. Coders also document this condition as acute akathisia caused by drug. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Drug induced or toxic related condition and Other nervous system disorders (often hereditary or degenerative).

Code Identity

ICD-10-CM Code
G25.71
Billable Status
Yes — Valid for Submission
Code Describes
Drug induced akathisia
Short Description
Drug induced akathisia
Same as the full description in the CMS dataset.
Parent Code
G25.7
Other and unspecified drug induced movement disorders

Code Classification

ChapterG00–G99Diseases of the nervous system
SectionG20-G26Extrapyramidal and movement disorders
CategoryG25Other extrapyramidal and movement disorders
This CodeG25.71Drug induced akathisia

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Acute akathisia caused by drug
  • Acute akathisia caused by neuroleptic
  • Akathisia
  • Akathisia caused by drug
  • Restlessness

Instructional NotesGuidance

Instructions from the official ICD-10-CM Tabular List that apply to G25.71: its own notes plus those printed at G25.7, G25, and Chapter 6. A note printed at a category, block or chapter applies to every code under it.

Applicable To

Conditions this code is used for: synonyms of the title or, for "other specified" codes, the conditions assigned to it. The list is not exhaustive.

  • Drug induced acathisia
  • Neuroleptic induced acute akathisia
  • Tardive akathisia

Excludes2

Not included here: the excluded condition is not part of this code, but a patient may have both, so both codes may be reported.

From G25 Other extrapyramidal and movement disorders applies to 16 codes
  • sleep related movement disorders (G47.6-)
From Chapter 6 (G00-G99) Diseases of the nervous system applies to 700 codes
  • certain conditions originating in the perinatal period (P04-P96)
  • certain infectious and parasitic diseases (A00-B99)
  • complications of pregnancy, childbirth and the puerperium (O00-O9A)
  • congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99)
  • endocrine, nutritional and metabolic diseases (E00-E88)
  • injury, poisoning and certain other consequences of external causes (S00-T88)
  • neoplasms (C00-D49)
  • symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)

Use Additional Code

Add a second code, after this one, to fully describe the condition.

From G25.7 Other and unspecified drug induced movement disorders applies to 3 codes
  • code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)

Source: CMS ICD-10-CM Tabular List. How to read instructional notes.

Referenced in Other NotesGuidance

Instructional notes printed at other codes that name G25.71, its category, or a range that includes it.

Excludes1 1

These codes carry an Excludes1 note naming G25.71: they are not reported together with it, unless the two conditions are unrelated.

  • R25 Abnormal involuntary movements
    specific movement disorders (G20-G26) names G20-G26, which includes this code

Excludes2 1

These codes carry an Excludes2 note naming G25.71: its condition is not part of those codes, and both may be reported when the patient has both.

  • F98.4 Stereotyped movement disorders
    movement disorders of organic origin (G20-G25) names G20-G25, which includes this code

Index to Diseases and InjuriesGuidance

Alphabetical index entries that point to this code.

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR INJ030
Drug induced or toxic related condition
Default principal diagnosis: inpatient Yes · outpatient Yes
CCSR NVS006
Other nervous system disorders (often hereditary or degenerative)
Default principal diagnosis: inpatient No · outpatient No

Clinical InformationClinical

  • Akathisia, Drug-Induced

    a condition associated with the use of certain medications and characterized by an internal sense of motor restlessness often described as an inability to resist the urge to move.

Patient EducationClinical

Drug Reactions

Most of the time, medicines make our lives better. They reduce aches and pains, fight infections, and control problems such as high blood pressure or diabetes. But medicines can also cause unwanted reactions, such as drug interactions, side effects, and allergies.

The full article covers:

  • What is a drug interaction?
  • What are side effects?
  • What are drug allergies?
  • How can I stay safe when taking medicines?

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert G25.71 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
333.99 Extrapyramidal dis NEC
Approximate The match is approximate rather than exact.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2026No changes
FY 2027CurrentCurrent code set, no changesEffective October 1, 2026 through September 30, 2027.

Questions About G25.71Overview

What is the ICD-10 code for drug induced akathisia?

The ICD-10-CM code for drug induced akathisia is G25.71 (sometimes written as G2571). It is billable on HIPAA-covered claims from October 1, 2026 through September 30, 2027.

Is G25.71 (Other and unspecified drug induced movement disorders) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report drug induced akathisia on HIPAA-covered claims from October 1, 2026 through September 30, 2027.

What MS-DRG does G25.71 group to?

When drug induced akathisia is the principal diagnosis on an inpatient stay, it groups to MS-DRG 57, 56, with relative weights from 1.2835 to 2.2649 depending on complications. Higher weights mean higher Medicare reimbursement.

Does G25.71 need an additional code?

When the condition applies, yes. The Use Additional Code note at G25.7, which applies to G25.71, reads: code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5). The additional code is reported after G25.71.

What is the ICD-9 equivalent of G25.71?

Under the General Equivalence Mappings, drug induced akathisia converts to ICD-9-CM 333.99 (extrapyramidal dis NEC). The mapping is approximate, so confirm the match fits the documentation.